Finder makes money from featured partners, but editorial opinions are our own. Advertiser Disclosure
How to buy Kezar Life Sciences stock
Learn how to easily invest in Kezar Life Sciences stock.
Kezar Life Sciences Inc is a biotechnology business based in the US. Kezar Life Sciences shares (KZR) are listed on the NASDAQ and all prices are listed in US Dollars. Kezar Life Sciences employs 56 staff and has a market cap (total outstanding shares value) of 0.00.
How to buy shares in Kezar Life Sciences
- Compare share trading platforms. Use our comparison table to help you find a platform that fits you.
- Open your brokerage account. Complete an application with your details.
- Confirm your payment details. Fund your account.
- Research the stock. Find the stock by name or ticker symbol – KZR – and research it before deciding if it's a good investment for you.
- Purchase now or later. Buy your desired number of shares with a market order or use a limit order to delay your purchase until the stock reaches a desired price.
- Check in on your investment. Optimize your portfolio by tracking your stock.
Kezar Life Sciences stock price (NASDAQ: KZR)Use our graph to track the performance of KZR stocks over time.
Kezar Life Sciences shares at a glance
|Latest market close||$8.72|
|52-week range||$4.31 - $18.55|
|50-day moving average||$9.79|
|200-day moving average||$11.33|
|Wall St. target price||$18.75|
|Dividend yield||$0 (0%)|
|Earnings per share (TTM)||$-1.05|
Buy Kezar Life Sciences shares from these brokeragesCompare special offers, low fees and a wide range of types of investments among top trading platforms.
*Signup bonus information updated weekly.
The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.
Is it a good time to buy Kezar Life Sciences stock?
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Kezar Life Sciences price performance over time
|1 week (2022-09-23)||8.73%|
|1 month (2022-08-30)||-11.38%|
|3 months (2022-06-30)||5.44%|
|6 months (2022-03-26)||N/A|
|1 year (2021-09-30)||0.93%|
|2 years (2020-09-30)||80.17%|
|3 years (2019-09-30)||165.85%|
|5 years (2017-09-26)||N/A|
Kezar Life Sciences financials
|Gross profit TTM||$0|
|Return on assets TTM||-16.63%|
|Return on equity TTM||-28.5%|
|Market capitalisation||$548.3 million|
TTM: trailing 12 months
Kezar Life Sciences share dividends
We're not expecting Kezar Life Sciences to pay a dividend over the next 12 months.
Kezar Life Sciences share price volatility
Over the last 12 months, Kezar Life Sciences's shares have ranged in value from as little as $4.31 up to $18.55. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Kezar Life Sciences's is 0.1488. This would suggest that Kezar Life Sciences's shares are less volatile than average (for this exchange).
Kezar Life Sciences overview
Kezar Life Sciences, Inc. , a clinical-stage biotechnology company, engages in the discovery and development of novel small molecule therapeutics to treat unmet needs in immune-mediated diseases and cancer in the United States. The company's lead product candidate is KZR-616, a selective immunoproteasome inhibitor that is in Phase 2 clinical trials for various indications, including lupus nephritis, dermatomyositis, and polymyositis; and Phase 1b clinical trials in systemic lupus erythematosus and lupus nephritis. Its preclinical products include KZR-261, a novel first-in-class protein secretion inhibitor for the treatment of KZR-261; and KZR-TBD for the treatment of oncology and immunology. The company was incorporated in 2015 and is based in South San Francisco, California. .
Kezar Life Sciences in the news
Kezar Life Sciences to Present Complete Results from the Phase 2 MISSION Trial of Zetomipzomib in Patients with Lupus Nephritis at the American College of Rheumatology Convergence 2022
Kezar Announces Inducement Grant Under NASDAQ Listing Rule 5635(c)(4)
Kezar Life Sciences to Participate in Three Upcoming Investor Conferences
Frequently asked questionsWhat percentage of Kezar Life Sciences is owned by insiders or institutions?
Currently 20.909% of Kezar Life Sciences shares are held by insiders and 82.062% by institutions. How many people work for Kezar Life Sciences?
Latest data suggests 56 work at Kezar Life Sciences. When does the fiscal year end for Kezar Life Sciences?
Kezar Life Sciences's fiscal year ends in December. Where is Kezar Life Sciences based?
Kezar Life Sciences's address is: 4000 Shoreline Court, South San Francisco, CA, United States, 94080 What is Kezar Life Sciences's ISIN number?
Kezar Life Sciences's international securities identification number is: US49372L1008 What is Kezar Life Sciences's CUSIP number?
Kezar Life Sciences's Committee on Uniform Securities Identification Procedures number is: 49372L100
More guides on Finder
How to buy YanGuFang International Group (YGF) stock when it goes public
Everything we know about the YanGuFang International Group IPO, plus information on how to buy in.
What are the FAANG stocks and how do you invest in them?
Looking to invest in tech? Here’s how to buy shares in the major tech companies, known as FAANG stocks.
How to buy soccer stocks
A simple guide to buying stocks in your favorite European soccer team.
How to buy Juventus stock
Steps to owning and managing JUVE, with 24-hour and historical pricing before you buy.
How to buy AS Roma stock
Steps to owning and managing ASR, with 24-hour and historical pricing before you buy.
How to buy Borussia Dortmund stock
Steps to owning and managing BVB, with 24-hour and historical pricing before you buy.
How to buy Lead Real Estate Co. (LRE) stock when it goes public
Everything we know about the Lead Real Estate Co. IPO, plus information on how to buy in.
How to buy Third Harmonic Bio (THRD) stock
Everything we know about the Third Harmonic Bio IPO, plus information on how to buy in.
How to buy LINKBANCORP (LNKB) stock
Everything we know about the LINKBANCORP IPO, plus information on how to buy in.
Here are the stocks that benefit from inflation, as well as industries to keep an eye on to reduce the impacts of inflation on your portfolio.
Ask an Expert